Topics Engaged In
-
- Topic
- Voices
- Last Post
-
-
New BRAF/MEK inhibitors coming to market
Started by:
in: Dosing and administration
- 1
- March 1, 2018 at 12:20 am
-
Adjuvant Immunotherapy in stage IIIA patients
Started by:
in: Expectations for therapy
- 1
- March 1, 2018 at 12:16 am
-
Influenza and Tamiflu and Immunotherapy
Started by:
in: Other
- 3
- February 25, 2018 at 10:12 pm
-
ASCO/NCCN guidlines now out
Started by:
in: Side-effect management
- 4
- February 23, 2018 at 5:53 pm
-
Reimbursement for infliximab
Started by:
in: Reimbursement
- 6
- February 17, 2018 at 11:10 pm
-
Family planning
Started by:
in: Fertility
- 4
- February 16, 2018 at 4:44 pm
-
Infusion times
Started by:
in: Dosing and administration
- 8
- February 15, 2018 at 3:41 pm
-
Practice volume
Started by:
in: Other
- 2
- February 15, 2018 at 3:37 pm
-
Professional Referral Network
Started by:
in: Other
- 4
- February 8, 2018 at 11:34 pm
-
Probiotics
Started by:
in: Side-effect management
- 5
- February 7, 2018 at 3:43 pm
-
Sugar and melanoma
Started by:
in: Nutrition
- 3
- January 31, 2018 at 8:43 pm
-
Adjuvant Ipi vs. Nivo
Started by:
in: Other
- 4
- January 31, 2018 at 8:37 pm
-
CNS Disease
Started by:
in: Side-effect management
- 4
- January 30, 2018 at 7:51 pm
-
Ocular herpes
Started by:
in: Side-effect management
- 5
- January 5, 2018 at 2:54 am
-
New BRAF/MEK inhibitors coming to market